These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11013012)

  • 101. Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis.
    Pavlovski D; Thundyil J; Monk PN; Wetsel RA; Taylor SM; Woodruff TM
    FASEB J; 2012 Sep; 26(9):3680-90. PubMed ID: 22651932
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Characterization of a polymorphism in the coding region of the human C5a anaphylatoxin receptor.
    Marceau F; Bachvarova M; Bergeron J; Bachvarov DR
    Immunogenetics; 1999 Jul; 49(7-8):618-9. PubMed ID: 10369919
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Increased inhibitory capacity of an anti-C5a complementary peptide following acetylation of N-terminal alanine.
    Okada N; Asai S; Hotta A; Miura N; Ohno N; Farkas I; Hau L; Okada H
    Microbiol Immunol; 2007; 51(4):439-43. PubMed ID: 17446684
    [TBL] [Abstract][Full Text] [Related]  

  • 104. A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds.
    Bunschoten A; Ippel JH; Kruijtzer JA; Feitsma L; de Haas CJ; Liskamp RM; Kemmink J
    Amino Acids; 2011 Feb; 40(2):731-40. PubMed ID: 20683629
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Inhibition of a membrane complement regulatory protein by a monoclonal antibody induces acute lethal shock in rats primed with lipopolysaccharide.
    Mizuno M; Nishikawa K; Okada N; Matsuo S; Ito K; Okada H
    J Immunol; 1999 May; 162(9):5477-82. PubMed ID: 10228027
    [TBL] [Abstract][Full Text] [Related]  

  • 106. A sensitive enzyme immunoassay for the quantitation of human C5a/C5a(desArg) anaphylatoxin using a monoclonal antibody with specificity for a neoepitope.
    Oppermann M; Schulze M; Götze O
    Complement Inflamm; 1991; 8(1):13-24. PubMed ID: 1710957
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Binding of raloxifene to human complement fragment 5a (
    Mishra R; Behera LM; Rana S
    J Biomol Struct Dyn; 2022 Feb; 40(3):982-994. PubMed ID: 32930050
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis.
    Furebring M; Håkansson LD; Venge P; Nilsson B; Sjölin J
    Crit Care; 2002 Aug; 6(4):363-70. PubMed ID: 12225614
    [TBL] [Abstract][Full Text] [Related]  

  • 109. A comprehensive structure-function map of the intracellular surface of the human C5a receptor. I. Identification of critical residues.
    Matsumoto ML; Narzinski K; Kiser PD; Nikiforovich GV; Baranski TJ
    J Biol Chem; 2007 Feb; 282(5):3105-21. PubMed ID: 17135254
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues.
    Nürge B; Schulz AL; Kaemmerer D; Sänger J; Evert K; Schulz S; Lupp A
    PLoS One; 2021; 16(2):e0246939. PubMed ID: 33606748
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The C5a anaphylatoxin receptor CD88 is expressed in presynaptic terminals of hippocampal mossy fibres.
    Crane JW; Baiquni GP; Sullivan RK; Lee JD; Sah P; Taylor SM; Noakes PG; Woodruff TM
    J Neuroinflammation; 2009 Nov; 6():34. PubMed ID: 19917081
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Increased C5a receptor expression in sepsis.
    Riedemann NC; Guo RF; Neff TA; Laudes IJ; Keller KA; Sarma VJ; Markiewski MM; Mastellos D; Strey CW; Pierson CL; Lambris JD; Zetoune FS; Ward PA
    J Clin Invest; 2002 Jul; 110(1):101-8. PubMed ID: 12093893
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells.
    Fayyazi A; Scheel O; Werfel T; Schweyer S; Oppermann M; Götze O; Radzun HJ; Zwirner J
    Immunology; 2000 Jan; 99(1):38-45. PubMed ID: 10651939
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Expression and induction of anaphylatoxin C5a receptors in the rat liver.
    Schlaf G; Schmitz M; Rothermel E; Jungermann K; Schieferdecker HL; Götze O
    Histol Histopathol; 2003 Jan; 18(1):299-308. PubMed ID: 12507307
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Analysis of the tissue distribution of the rat C5a receptor and inhibition of C5a-mediated effects through the use of two MoAbs.
    Rothermel E; Götze O; Zahn S; Schlaf G
    Scand J Immunol; 2000 Oct; 52(4):401-10. PubMed ID: 11013012
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
    Schlaf G; Schieferdecker HL; Rothermel E; Jungermann K; Götze O
    Lab Invest; 1999 Oct; 79(10):1287-97. PubMed ID: 10532591
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
    J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
    [TBL] [Abstract][Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.